Jeff Yass’s NeuroOne Medical Technologies NMTC Stock Holding History

Jeff Yass’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.1K	Buy	+13,520	New	+$55.2K	﹤0.01%	12894
2025 Q4	–	Sell	-8,863	Closed	-$47.3K	–	13178
2025 Q3	$47.3K	Buy	+8,863	New	+$43.4K	﹤0.01%	11877
2023 Q1	–	Sell	-14,321	Closed	-$103K	–	13178
2022 Q4	$103K	Buy	+14,321	New	+$128K	﹤0.01%	10940
2022 Q2	–	Sell	-5,796	Closed	-$38K	–	13594
2022 Q1	$38K	Buy	+5,796	New	+$70.2K	﹤0.01%	12427

Other funds holding NMTC

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Jeff Yass's NMTC Position: Q2 2026 in Review

Jeff Yass opened a new position in NeuroOne Medical Technologies (NMTC) in Q2 2026: 13,520 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #12894 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NMTC as recently as Q3 2025.

Jeff Yass first reported a position in NMTC in Q1 2022 and has held it in 4 quarters since. The position peaked at $103K in Q4 2022. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

Jeff Yass held 13,520 shares of NeuroOne Medical Technologies worth $41.1K as of Q2 2026.
NeuroOne Medical Technologies was a new Jeff Yass position in Q2 2026.
NeuroOne Medical Technologies made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12894 holding.
Jeff Yass first reported a position in NeuroOne Medical Technologies in Q1 2022 and has held it in 4 quarters since.
Jeff Yass's NeuroOne Medical Technologies position peaked at $103K in Q4 2022.
27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.